GlassScriptPhysician profile
Prashank Neupane
NPI 1750941001
$1,149.10
in general payments reported to CMS, 2019-2025
7 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $163 · 2024: $672 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $518.71 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pulmonx Corporation | $173.60 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Stryker Corporation | $135.49 | 2025 | Flowtriever |
| Genzyme Corporation | $130.68 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $112.76 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $39.36 | 2024 | Dupixent |
| Merck Sharp & Dohme LLC | $38.50 | 2024 | Zerbaxa, Recarbrio, Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashank Neupane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.